Injectable progestin contraceptive use and risk of HIV infection in a South African family planning cohort
I Kleinschmidt, H Rees, S Delany, D Smith, N Dinat… - Contraception, 2007 - Elsevier
OBJECTIVE: To investigate whether the incidence of HIV infection is higher among sexually
active women using depot medroxyprogesterone acetate (DMPA) or noresthisterone
enanthate (NET-EN) injections for contraception than among women using nonhormonal or
no contraception. METHODS: Five hundred and fifty-one initially HIV-negative women were
followed up for a total of 491 person-years. Participants were interviewed, counselled,
examined, tested for HIV and other STIs, and treated, at three monthly intervals for 1 year …
active women using depot medroxyprogesterone acetate (DMPA) or noresthisterone
enanthate (NET-EN) injections for contraception than among women using nonhormonal or
no contraception. METHODS: Five hundred and fifty-one initially HIV-negative women were
followed up for a total of 491 person-years. Participants were interviewed, counselled,
examined, tested for HIV and other STIs, and treated, at three monthly intervals for 1 year …
Showing the best result for this search. See all results